Form 4 for IDXX Idexx Laboratories
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-13 · accession 0000874716-25-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-14 | 2025-05-13 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | $263.81 | +2,683 | 4,708 | +132% | +$707.8K |
| D | 2025-05-14 | 2025-05-13 | IDXX | JUNIUS DANIEL M | Dir | S - Sale+OE | $506.41 | -2,683 | 3,304 | -45% | -$1.36M |
| DM | 2025-05-14 | 2025-05-13 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | $0.00 | -2,683 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-13 | M | A | 1,279 | $283.59 | 5,987 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-13 | S | D | 2,683 | $506.41 | 3,304 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-13 | M | A | 1,404 | $245.79 | 4,708 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-05-13 | M | D | 1,279 | $0.00 | 0 | D | $283.59 · — to 2030-05-05 | 1,279 Common Stock | (F2) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier. |
| 5 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-05-13 | M | D | 1,404 | $0.00 | 0 | D | $245.79 · — to 2029-05-07 | 1,404 Common Stock | (F1) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event was earlier. |